{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "They were randomly separated into two groups based on endovascular techniques performed with and without DEB."
      },
      "Participants": {
        "score": 2,
        "evidence": "Between 2017 and 2021, we prospectively recruited patients with severe PIRCS for PTAS."
      },
      "Intervention": {
        "score": 2,
        "evidence": "They were randomly separated into two groups based on endovascular techniques performed with and without DEB."
      },
      "Objective": {
        "score": 1,
        "evidence": "Objective: To investigate the technical safety and outcome of in-stent restenosis (ISR) prevention with drug-eluting balloon (DEB) in patients with postirradiated carotid stenosis (PIRCS) undergoing percutaneous angioplasty and stenting (PTAS)."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "Preprocedural and early postprocedural (within 24 hours) MRI, short-term ultrasonography (6 months after PTAS), and long-term CT angiography (CTA)/MR angiography (MRA), 12 months after PTAS, were performed."
      },
      "Randomisation_Allocation": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Blinding": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "Sixty-six (30 with and 36 without DEB) subjects were enrolled, with one failure in techniques."
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "For 65 patients in the DEB versus conventional groups, technical neurological symptoms within 1\u2009month (1/29 (3.4%) vs 0/36; P=0.197) and REIL numbers within 24 hours (1.0\u00b12.1 vs 1.3\u00b11.5; P=0.592) after PTAS showed no differences."
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "The degree of in-stent stenosis (45.93\u00b120.86 vs 26.58\u00b18.75; P<0.001) was higher, and there were more subjects (n=8, 38.9% vs 1, 3.4%; P=0.029) with significant ISR (\u2265 50%) in the conventional group than in the DEB group on long-term CTA/MRA."
      },
      "Harms": {
        "score": 1,
        "evidence": "Technical safety was evaluated based on periprocedural neurological complications and the number of recent embolic ischemic lesions (REIL) in the treated brain territory on diffusion-weighted imaging of early postprocedural MRI."
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 15,
    "max_score": 25
  },
  "model": "gpt-4o"
}